{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:22:17Z","timestamp":1794378137309,"version":"4.9.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"DOI":"10.1007\/s10930-026-10359-z","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:32:04Z","timestamp":1791826324000},"page":"817-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Identification of IL-17\u00a0a Small-Molecule Inhibitors as Potential Therapeutics for Plaque Psoriasis Through e-Pharmacophore Screening, Molecular Docking, and Molecular Dynamics Simulation"],"prefix":"10.1007","volume":"45","author":[{"given":"Selvakumar","family":"Rajendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anantha Krishnan","family":"Dhanabalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram Srinivasa","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jebiti","family":"Haribabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunachalam","family":"Arulraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varaprasad","family":"Kokkarachedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunasekaran","family":"Krishnasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"4","key":"10359_CR1","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL (2019) The IL-17 family of cytokines in health and disease. Immunity 50(4):892\u2013906","journal-title":"Immunity"},{"issue":"10","key":"10359_CR2","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1007\/s12325-022-02241-y","volume":"39","author":"I Turchin","year":"2022","unstructured":"Turchin I, Bourcier M (2022) The role of interleukins in the pathogenesis of dermatological immune-mediated diseases. Adv Therapy Oct; 39(10):4474\u20134508","journal-title":"Adv Therapy"},{"issue":"1","key":"10359_CR3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","volume":"138","author":"M Akdis","year":"2016","unstructured":"Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, Frei R (2016) Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 138(1):984\u20131010","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10359_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.cellsig.2010.11.022","volume":"23","author":"S Chang","year":"2011","unstructured":"Chang S, Hee, Chen, Dong (2011) Signaling of Interleukin-17 Family Cytokines in Immunity and Inflammation. Cell Signal 23(7):1069\u20131075. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656810003487","journal-title":"Cell Signal"},{"issue":"3","key":"10359_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"1","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN (2021) Psoriasis: a brief overview. Clin Med 1(3):170\u2013173","journal-title":"Clin Med"},{"key":"10359_CR6","first-page":"369","volume":"28","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IY, Kontopantelis E, Augustin M, Griffiths CE, Ashcroft DM (2020) National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ May 28:369","journal-title":"BMJ"},{"key":"10359_CR7","first-page":"8","volume":"16","author":"G Damiani","year":"2021","unstructured":"Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, Guo C, Dellavalle R, Grada A, Wong P, La Vecchia C (2021) The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med Dec 16:8","journal-title":"Front Med"},{"issue":"1","key":"10359_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13555-015-0092-3","volume":"6","author":"M Campa","year":"2016","unstructured":"Campa M, Mansouri B, Warren R, Menter A (2016) A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis. Dermatology Therapy 6(1):1\u201312","journal-title":"Dermatology Therapy"},{"issue":"11","key":"10359_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11):1133\u20131141","journal-title":"Nat Immunol"},{"issue":"9","key":"10359_CR10","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/genes13091643","volume":"13","author":"EV Meehan","year":"2022","unstructured":"Meehan EV, Wang K (2022) Interleukin-17 family cytokines in metabolic disorders and cancer. Genes Sep 13(9):1643","journal-title":"Genes"},{"key":"10359_CR11","first-page":"1","volume":"48","author":"R El-Mallah","year":"2021","unstructured":"El-Mallah R, Saab AA, Nassar N (2021) Serum interleukin-17 and estradiol levels in postmenopausal women in relation to osteoporosis. Egypt Rheumatol Rehabilitation Dec; 48:1\u20137","journal-title":"Egypt Rheumatol Rehabilitation"},{"issue":"1","key":"10359_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/jcm13010164","volume":"13","author":"M Sisto","year":"2023","unstructured":"Sisto M, Lisi S (2023) Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases. J Clin Med 13(1):164","journal-title":"J Clin Med"},{"issue":"7","key":"10359_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm.3895","volume":"21","author":"MW Teng","year":"2015","unstructured":"Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova JL, Cooper AM, Cua DJ (2015) IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med Jul; 21(7):719\u2013729","journal-title":"Nat Med"},{"issue":"3","key":"10359_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/eji.200839134","volume":"39","author":"B Stockinger","year":"2009","unstructured":"Stockinger B, Veldhoen M, Hirota K (2009) Modulation of Th17 Development and Function by Activation of the Aryl Hydrocarbon Receptor - the Role of Endogenous Ligands. Eur J Immunol 39(3):652\u2013654. https:\/\/doi.org\/10.1002\/eji.200839134","journal-title":"Eur J Immunol"},{"issue":"1","key":"10359_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187(1):490\u2013500","journal-title":"J Immunol"},{"key":"10359_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/TCRM.S111107","volume":"13","author":"TL Hanley","year":"2017","unstructured":"Hanley TL, Yiu ZZ (2017) Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab. Ther Clin Risk Manag Mar 13:315\u2013323","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10359_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5114\/ada.2016.61599","volume":"33","author":"A Wasilewska","year":"2016","unstructured":"Wasilewska A, Winiarska M, Olszewska M, Rudnicka L (2016) Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases. Adv Dermatology Allergology\/Post\u0119py Dermatologii i Alergologii 33(4):247\u2013252","journal-title":"Adv Dermatology Allergology\/Post\u0119py Dermatologii i Alergologii"},{"issue":"11","key":"10359_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/ph15111365","volume":"15","author":"V Eshwar","year":"2022","unstructured":"Eshwar V, Kamath A, Shastry R, Shenoy AK, Kamath P (2022) A review of the safety of interleukin-17A inhibitor secukinumab. Pharmaceuticals 15(11):1365","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10359_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/cimb44050127","volume":"26","author":"L \u021aiburc\u0103","year":"2022","unstructured":"\u021aiburc\u0103 L, Bembea M, Zaha DC, Jurca AD, Vesa CM, Ra\u021biu IA, Jurca CM (2022) The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases. Curr Issues Mol Biol Apr 26(5):1851\u20131866","journal-title":"Curr Issues Mol Biol"},{"key":"10359_CR20","doi-asserted-by":"publisher","unstructured":"Reich K, Papp KA, Blauvelt A, Tyring SK, Sinclair R, Thaci D, Nograles K, Mehta A, Cichanowitz N, Li Q, Liu K, La Rosa C, Green S, Kimball AB. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. The Lancet. 2017. 390(10091):276\u2013288. https:\/\/doi.org\/10.1016\/S0140-6736(17)31279-5","DOI":"10.1016\/S0140-6736(17)31279-5"},{"issue":"1","key":"10359_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2015.01.018","volume":"136","author":"JG Krueger","year":"2015","unstructured":"Krueger JG, Ferris LK, Menter A, Wagner F, White A, Visvanathan S, Lalovic B, Aslanyan S, Wang EE, Hall D, Solinger A (2015) Anti\u2013IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 136(1):116\u2013124","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10359_CR22","doi-asserted-by":"publisher","first-page":"30859","DOI":"10.1038\/srep30859","volume":"166","author":"S Liu","year":"2016","unstructured":"Liu S, Dakin LA, Xing L, Withka JM, Sahasrabudhe PV, Li W, Banker ME, Balbo P, Shanker S, Chrunyk BA, Guo Z (2016) Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Sci Rep 6(1):30859","journal-title":"Sci Rep"},{"issue":"5","key":"10359_CR23","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/cimb44050127","volume":"26","author":"L \u021aiburc\u0103","year":"2022","unstructured":"\u021aiburc\u0103 L, Bembea M, Zaha DC, Jurca AD, Vesa CM, Ra\u021biu IA, Jurca CM (2022) The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases. Curr Issues Mol Biol Apr 26(5):1851\u20131866","journal-title":"Curr Issues Mol Biol"},{"issue":"5","key":"10359_CR24","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1021\/acs.jmedchem.5b01693","volume":"10","author":"A Espada","year":"2016","unstructured":"Espada A, Broughton H, Jones S, Chalmers MJ, Dodge JA (2016) A binding site on IL-17A for inhibitory macrocycles revealed by hydrogen\/deuterium exchange mass spectrometry. J Med Chem 10(5):2255\u20132260","journal-title":"J Med Chem Mar"},{"issue":"1","key":"10359_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1039\/C7MD00464H","volume":"9","author":"W Wang","year":"2018","unstructured":"Wang W, Groves MR, D\u00f6mling A (2018) Artificial Macrocycles as IL-17A\/IL- 17RA Antagonists. MedChemComm 9(1):22\u201326. https:\/\/doi.org\/10.1039\/C7MD00464H","journal-title":"MedChemComm"},{"issue":"7491","key":"10359_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ejmech.2018.06.019","volume":"155","author":"A Reiers\u00f8lmoen","year":"2018","unstructured":"Reiers\u00f8lmoen A, Christin J, Han E, Sundby, B\u00e5rd H (2018) Identification of Fused Pyrimidines as Interleukin 17 Secretion Inhibitors. Eur J Med Chem 155(7491):562\u2013578. https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.019","journal-title":"Eur J Med Chem"},{"issue":"10","key":"10359_CR27","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/ijms19103089","volume":"19","author":"M Hlavni\u010dkov\u00e1","year":"2018","unstructured":"Hlavni\u010dkov\u00e1 M, Kucha\u0159 M, Osi\u010dka R, Va\u0148kov\u00e1 L, Petrokov\u00e1 H, Mal\u00fd M, \u010cern\u00fd J, Arenberger P, Mal\u00fd P (2018) ABD-derived protein blockers of human IL-17 receptor a as non-IgG alternatives for modulation of IL-17-dependent pro-inflammatory axis. Int J Mol Sci 19(10):3089","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10359_CR28","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1021\/ci800154w","volume":"48","author":"W Deng","year":"2008","unstructured":"Deng W, Verlinde CLMJ (2008) Evaluation of Different Virtual Screening Programs for Docking in a Charged Binding Pocket. J Chem Inf Model 48(10):2010\u20132020. http:\/\/pubs.acs.org\/doi\/abs\/https:\/\/doi.org\/10.1021\/ci800154w","journal-title":"J Chem Inf Model"},{"key":"10359_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Friesner RA (2006) PHASE: a new engine for pharmacophore perception, 3D QSR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des Oct; 20:647\u2013671","journal-title":"J Comput Aided Mol Des"},{"issue":"5","key":"10359_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","volume":"67","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Rao SN (2006) PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des May; 67(5):370\u2013372","journal-title":"Chem Biol Drug Des"},{"issue":"21","key":"10359_CR31","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013 ligand complexes. J Med Chem 49(21):6177\u20136196","journal-title":"J Med Chem"},{"issue":"10","key":"10359_CR32","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1021\/ci900212v","volume":"49","author":"NK Salam","year":"2009","unstructured":"Salam NK, Roberto, Nuti, Sherman W (2009) Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis. J Chem Inf Model 49(10):2356\u20132368. http:\/\/pubs.acs.org\/doi\/abs\/https:\/\/doi.org\/10.1021\/ci900212v","journal-title":"J Chem Inf Model"},{"issue":"7","key":"10359_CR33","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"25","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem Mar 25(7):1739\u20131749","journal-title":"J Med Chem"},{"issue":"8","key":"10359_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10822-009-9268-1","volume":"23","author":"K Loving","year":"2009","unstructured":"Loving K, Salam NK, Sherman W (2009) Energetic Analysis of Fragment Docking and Application to Structure-Based Pharmacophore Hypothesis Generation. J Comput Aided Mol Des 23(8):541\u2013554. http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s10822-009-9268-1","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"10359_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/ci600426e","volume":"47","author":"J-F Truchon","year":"2007","unstructured":"Truchon J-F, Bayly CI (2007) Evaluating Virtual Screening Methods: Good and Bad Metrics for the \u2018Early Recognition\u2019 Problem. J Chem Inf Model 47(2):488\u2013508. http:\/\/pubs.acs.org\/doi\/abs\/https:\/\/doi.org\/10.1021\/ci600426e","journal-title":"J Chem Inf Model"},{"issue":"7","key":"10359_CR36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/jmr.2363","volume":"27","author":"P Vijayalakshmi","year":"2014","unstructured":"Vijayalakshmi P, Selvaraj C, Shafreen RM, Singh SK, Pandian SK, Daisy P (2014) Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus. J Mol Recognit Jul; 27(7):429\u2013437","journal-title":"J Mol Recognit"},{"issue":"9","key":"10359_CR37","doi-asserted-by":"publisher","first-page":"14531","DOI":"10.1002\/jcb.28714","volume":"120","author":"A Manhas","year":"2019","unstructured":"Manhas A, Patel D, Mohsin Y, Lone, Jha PC (2019) Identification of Natural Compound Inhibitors against Pf DXR: A Hybrid Structure-based Molecular Modeling Approach and Molecular Dynamics Simulation Studies. J Cell Biochem 120(9):14531\u201314543. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/jcb.28714","journal-title":"J Cell Biochem"},{"issue":"4","key":"10359_CR38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jmgm.2008.09.002","volume":"27","author":"H Wang","year":"2008","unstructured":"Wang H, Aslanian R, Vincent S, Madison (2008) Induced-Fit Docking of Mometasone Furoate and Further Evidence for Glucocorticoid Receptor 17\u03b1 Pocket Flexibility. J Mol Graph Model 27(4):512\u2013521. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332630800106X","journal-title":"J Mol Graph Model"},{"key":"10359_CR39","unstructured":"Schr\u00f6dinger, LLC (2014) QikProp, Schr\u00f6dinger Release 2014-2. Schr\u00f6dinger, LLC, New York, NY"},{"issue":"5","key":"10359_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00894-015-2654-9","volume":"21","author":"T Liu","year":"2015","unstructured":"Liu T, Chen M, Lu B (2015) Parameterization for Molecular Gaussian Surface and a Comparison Study of Surface Mesh Generation. J Mol Model 21(5):113. http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00894-015-2654-9","journal-title":"J Mol Model"},{"issue":"15","key":"10359_CR41","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1080\/07391102.2017.1406824","volume":"36","author":"S Iqbal","year":"2018","unstructured":"Iqbal S, Krishnan DA, Gunasekaran K (2018) Identification of Potential PKC Inhibitors through Pharmacophore Designing, 3D-QSAR and Molecular Dynamics Simulations Targeting Alzheimer\u2019s Disease. J Biomol Struct Dynamics 36(15):4029\u20134044. https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/07391102.2017.1406824","journal-title":"J Biomol Struct Dynamics"},{"issue":"4","key":"10359_CR42","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.str.2016.02.017","volume":"5","author":"PD Adams","year":"2016","unstructured":"Adams PD, Aertgeerts K, Bauer C, Bell JA, Berman HM, Bhat TN, Blaney JM, Bolton E, Bricogne G, Brown D, Burley SK (2016) Outcome of the first wwPDB\/CCDC\/D3R ligand validation workshop. Structure Apr 5(4):502\u2013508","journal-title":"Structure"},{"issue":"1\u20133","key":"10359_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"A Lipinski, Christopher","year":"1997","unstructured":"Lipinski, Christopher A, Franco Lombardo BW, Dominy, Paul J, Feeney (1997) Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Adv Drug Deliv Rev 23(1\u20133):3\u201325. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X96004231","journal-title":"Adv Drug Deliv Rev"},{"key":"10359_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jmgm.2017.06.001","volume":"76","author":"A Dhanabalan","year":"2017","unstructured":"Dhanabalan A, Krishnan M, Kesherwani D, Velmurugan, Gunasekaran K (2017) Identification of New BACE1 Inhibitors Using Pharmacophore and Molecular Dynamics Simulations Approach. J Mol Graph Model 76:56\u201369. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326316304260","journal-title":"J Mol Graph Model"},{"issue":"4","key":"10359_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/157340909789577847","volume":"5","author":"R Galeazzi","year":"2009","unstructured":"Galeazzi R (2009) Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications. Curr Comput Aided-Drug Des 5(4):225\u2013240. http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article& issn=1573-4099&volume=5&issue=4&spage=225","journal-title":"Curr Comput Aided-Drug Des"},{"issue":"19","key":"10359_CR46","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1021\/jp077018h","volume":"15112","author":"P Maragakis","year":"2008","unstructured":"Maragakis P, Lindorff-Larsen K, Eastwood MP, Dror RO, Klepeis JL, Arkin IT, Jensen M\u00d8, Xu H, Trbovic N, Friesner RA, Palmer AG (2008) Microsecond molecular dynamics simulation shows effect of slow loop dynamics on backbone amide order parameters of proteins. J Phys Chem B May 15112(19):6155\u20136158","journal-title":"J Phys Chem B"},{"key":"10359_CR47","doi-asserted-by":"publisher","unstructured":"Selvakumar R, Anantha Krishnan D, Ramakrishnan C, Velmurugan D, Gunasekaran K. Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches. J Biomol Struct Dyn. 2020. 38(3):682\u2013696. https:\/\/doi.org\/10.1080\/07391102.2019.1585291","DOI":"10.1080\/07391102.2019.1585291"},{"issue":"7","key":"10359_CR48","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham III, T. E (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9(7):3084\u20133095","journal-title":"J Chem Theory Comput"},{"issue":"4","key":"10359_CR49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/prot.340170408","volume":"17","author":"A Amadei","year":"1993","unstructured":"Amadei A, Linssen AB, Berendsen HJ (1993) Essential dynamics of proteins. Proteins Struct Funct Bioinform 17(4):412\u2013425","journal-title":"Proteins Struct Funct Bioinform"},{"issue":"3","key":"10359_CR50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/prot.340110305","volume":"11","author":"T Ichiye","year":"1991","unstructured":"Ichiye T, Karplus M (1991) Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins Struct Funct Bioinform 11(3):205\u2013217","journal-title":"Proteins Struct Funct Bioinform"},{"key":"10359_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","volume-title":"Protein dynamics","author":"CC David","year":"2014","unstructured":"David CC, Jacobs DJ (2014) Principal component analysis: a method for determining the essential dynamics of proteins. Protein dynamics. Humana, Totowa, NJ, pp 193\u2013226"},{"issue":"4","key":"10359_CR52","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1006\/jmbi.1995.0514","volume":"252","author":"PH H\u00fcnenberger","year":"1995","unstructured":"H\u00fcnenberger PH, Mark AE, Van Gunsteren WF (1995) Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations. J Mol Biol 252(4):492\u2013503","journal-title":"J Mol Biol"},{"issue":"21","key":"10359_CR53","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","volume":"22","author":"BJ Grant","year":"2006","unstructured":"Grant BJ, Rodrigues AP, ElSawy KM, McCammon JA, Caves LS (2006) Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics 22(21):2695\u20132696","journal-title":"Bioinformatics"},{"issue":"9","key":"10359_CR54","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1021\/ct9001812","volume":"5","author":"CL McClendon","year":"2009","unstructured":"McClendon CL, Friedland G, Mobley DL, Amirkhani H, Jacobson MP (2009) Quantifying correlations between allosteric sites in thermodynamic ensembles. J Chem Theory Comput 5(9):2486\u20132502","journal-title":"J Chem Theory Comput"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-026-10359-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-026-10359-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-026-10359-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:29:17Z","timestamp":1794374957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-026-10359-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10359"],"URL":"https:\/\/doi.org\/10.1007\/s10930-026-10359-z","relation":{},"ISSN":["1875-8355"],"issn-type":[{"value":"1875-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}